Biotech · Private company
Tarveda Therapeutics
Track this companyFree. Adds Tarveda Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- fluorouracilPhase 2 · CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Folinic acidPhase 2 · CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- NiraparibPhase 2 · CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- PEN-221Phase 2 · Neuroendocrine TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PEN-866 SodiumPhase 2 · CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- PEN-866 in Patients With Advanced Solid MalignanciesPHASE1_PHASE2 · UNKNOWN · started Aug 29, 2017ClinicalTrials.gov NCT03221400 · fetched Nov 12, 2026
- PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung CancersPHASE1_PHASE2 · COMPLETED · started Dec 8, 2016ClinicalTrials.gov NCT02936323 · fetched Nov 12, 2026